Clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for GI diseases.
1
Funding Rounds
$5.0m
Money raised
Name | Phone | Social networks | |
---|---|---|---|
Al* Ri | - | - | - |
Ja*** Sa*** | - | - | - |
Ch J. Ca** | - | - | - |
Te*** Co**** | - | - | |
Ed**** J. Bo** | - | - | - |